Sarepta Therapeutics Inc (SRPT)
136.43
+5.93
(+4.54%)
USD |
NASDAQ |
Nov 27, 13:39
Sarepta Therapeutics Shares Outstanding: 95.52M for Nov. 1, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
November 01, 2024 | 95.52M |
September 30, 2024 | 95.49M |
August 02, 2024 | 95.37M |
June 30, 2024 | 95.28M |
April 26, 2024 | 94.52M |
April 08, 2024 | 94.51M |
March 31, 2024 | 94.49M |
February 23, 2024 | 93.86M |
December 31, 2023 | 93.73M |
October 27, 2023 | 93.55M |
September 30, 2023 | 93.54M |
July 28, 2023 | 93.28M |
June 30, 2023 | 93.27M |
April 27, 2023 | 93.15M |
April 14, 2023 | 93.14M |
March 31, 2023 | 93.14M |
March 07, 2023 | 91.83M |
February 23, 2023 | 87.98M |
December 31, 2022 | 87.95M |
October 28, 2022 | 87.78M |
September 30, 2022 | 87.77M |
July 29, 2022 | 87.57M |
June 30, 2022 | 87.54M |
April 29, 2022 | 87.50M |
April 19, 2022 | 87.50M |
Date | Value |
---|---|
April 08, 2022 | 87.50M |
March 31, 2022 | 87.50M |
February 24, 2022 | 87.15M |
December 31, 2021 | 87.13M |
October 29, 2021 | 87.08M |
October 18, 2021 | 87.06M |
September 30, 2021 | 79.96M |
July 30, 2021 | 79.84M |
June 30, 2021 | 79.83M |
April 30, 2021 | 79.77M |
April 12, 2021 | 79.75M |
April 09, 2021 | 79.75M |
March 31, 2021 | 79.75M |
February 19, 2021 | 79.42M |
December 31, 2020 | 79.37M |
October 30, 2020 | 78.91M |
September 30, 2020 | 78.79M |
July 31, 2020 | 78.51M |
June 30, 2020 | 78.43M |
May 01, 2020 | 77.99M |
April 13, 2020 | 77.96M |
April 06, 2020 | 77.96M |
March 31, 2020 | 77.96M |
February 21, 2020 | 77.78M |
February 14, 2020 | 77.07M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
75.18M
Minimum
Dec 31 2019
95.52M
Maximum
Nov 01 2024
86.21M
Average
87.50M
Median
Apr 08 2022
Shares Outstanding Benchmarks
Eli Lilly and Co | 949.32M |
Catalyst Pharmaceuticals Inc | 119.27M |
Regeneron Pharmaceuticals Inc | 109.89M |
Vertex Pharmaceuticals Inc | 257.53M |
Viking Therapeutics Inc | 111.44M |